JAZZ - Jazz Pharmaceuticals EPS beats by $0.48 beats on revenue August, 06 2019 04:09 PM Jazz Pharmaceuticals plc Jazz Pharmaceuticals (NASDAQ:JAZZ): Q2 Non-GAAP EPS of $4.05 beats by $0.48; GAAP EPS of $4.45 beats by $3.73.Revenue of $534.13M (+6.7% Y/Y) beats by $26.9M.Shares +0.5%.Press ReleaseMore news on: Jazz Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news,